178 related articles for article (PubMed ID: 2827353)
1. The impact of cytomegalovirus infection on seronegative recipients of seropositive donor kidneys versus seropositive recipients treated with cyclosporine-prednisone immunosuppression.
Johnson PC; Lewis RM; Golden DL; Oefinger PE; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1988 Jan; 45(1):116-21. PubMed ID: 2827353
[TBL] [Abstract][Full Text] [Related]
2. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
[TBL] [Abstract][Full Text] [Related]
3. Incidence and morbidity of cytomegalovirus disease associated with a seronegative recipient receiving seropositive donor-specific transfusion and living-related donor transplantation. A multicenter evaluation.
Weir MR; Henry ML; Blackmore M; Smith J; First MR; Irwin B; Shen S; Genemans G; Alexander JW; Corry RJ
Transplantation; 1988 Jan; 45(1):111-6. PubMed ID: 2827352
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus as a risk factor in living-related renal transplantation. A prospective study.
Pollak R; Barber PL; Prusak BF; Mozes MF
Ann Surg; 1987 Mar; 205(3):302-4. PubMed ID: 3030201
[TBL] [Abstract][Full Text] [Related]
5. Prevention of CMV infection by screening for CMV antibodies in renal allograft recipients and their blood and kidney donors.
Metselaar HJ; Ploeg RJ; Van Loon AM; Weiland HT; Rothbarth PH; Paul LC; Brand A; Schaafsma R; Hendriks GF; Jeekel J
Scand J Infect Dis; 1988; 20(2):135-9. PubMed ID: 2840730
[TBL] [Abstract][Full Text] [Related]
6. CMV mismatch does not affect patient and graft survival in UK renal transplant recipients.
Johnson RJ; Clatworthy MR; Birch R; Hammad A; Bradley JA
Transplantation; 2009 Jul; 88(1):77-82. PubMed ID: 19584684
[TBL] [Abstract][Full Text] [Related]
7. Reduction by combination prophylactic therapy with CMV hyperimmune globulin and acyclovir of the risk of primary CMV disease in renal transplant recipients.
Nicol DL; MacDonald AS; Belitsky P; Lee S; Cohen AD; Bitter-Suermann H; Lowen J; Whalen A
Transplantation; 1993 Apr; 55(4):841-6. PubMed ID: 8386404
[TBL] [Abstract][Full Text] [Related]
8. The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation.
Smiley ML; Wlodaver CG; Grossman RA; Barker CF; Perloff LJ; Tustin NB; Starr SE; Plotkin SA; Friedman HM
Transplantation; 1985 Aug; 40(2):157-61. PubMed ID: 2992130
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus infection and disease in renal transplant patients treated with cyclosporin. A prospective study.
Bosch FH; Hoitsma AJ; Janssen HP; van Loon AM; Koene RA
Transpl Int; 1989 Aug; 2(2):92-5. PubMed ID: 2551314
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3.
Hibberd PL; Tolkoff-Rubin NE; Cosimi AB; Schooley RT; Isaacson D; Doran M; Delvecchio A; Delmonico FL; Auchincloss H; Rubin RH
Transplantation; 1992 Jan; 53(1):68-72. PubMed ID: 1310173
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
[TBL] [Abstract][Full Text] [Related]
12. The effects of cytomegalovirus serology on graft and recipient survival in cadaveric renal transplantation: implications for organ allocation.
Schnitzler MA; Woodward RS; Brennan DC; Spitznagel EL; Dunagan WC; Bailey TC
Am J Kidney Dis; 1997 Mar; 29(3):428-34. PubMed ID: 9041220
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients.
Sagedal S; Nordal KP; Hartmann A; Degré M; Holter E; Foss A; Osnes K; Leivestad T; Fauchald P; Rollag H
Transplantation; 2000 Oct; 70(8):1166-74. PubMed ID: 11063335
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus antibody status and kidney transplantation.
Terasaki PI; Yuge J; Cecka JM; Gjertson DW
Clin Transpl; 1994; ():509-18. PubMed ID: 7547579
[TBL] [Abstract][Full Text] [Related]
15. A prospective study on infection with cytomegalovirus in renal allograft recipients immunosuppressed with cyclosporine A and low dose prednisone.
Arnfred J; Nielsen CM; Spencer ES; Andersen HK
Scand J Infect Dis; 1987; 19(3):297-302. PubMed ID: 3039651
[TBL] [Abstract][Full Text] [Related]
16. Impaired direct priming of CD8 T cells by donor-derived cytomegalovirus following kidney transplantation.
Shabir S; Kaul B; Pachnio A; Banham GD; Smith H; Chand S; Jham S; Harper L; Ball S; Rahbar A; Söderberg-Nauclér C; Moss P; Borrows R
J Am Soc Nephrol; 2013 Oct; 24(10):1698-708. PubMed ID: 23847277
[TBL] [Abstract][Full Text] [Related]
17. A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients.
Flechner SM; Avery RK; Fisher R; Mastroianni BA; Papajcik DA; O'Malley KJ; Goormastic M; Goldfarb DA; Modlin CS; Novick AC
Transplantation; 1998 Dec; 66(12):1682-8. PubMed ID: 9884259
[TBL] [Abstract][Full Text] [Related]
18. Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial.
Witzke O; Hauser IA; Bartels M; Wolf G; Wolters H; Nitschke M;
Transplantation; 2012 Jan; 93(1):61-8. PubMed ID: 22094954
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus infection in renal transplant recipients.
Carstens J; Andersen HK; Spencer E; Madsen M
Transpl Infect Dis; 2006 Dec; 8(4):203-12. PubMed ID: 17116133
[TBL] [Abstract][Full Text] [Related]
20. Incidence of cytomegalovirus disease in cyclosporine-treated renal transplant recipients based on donor/recipient pretransplant immunity.
Weir MR; Irwin BC; Maters AW; Genemans G; Shen SY; Charache P; Williams GM
Transplantation; 1987 Feb; 43(2):187-93. PubMed ID: 3027930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
